emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Private Group led by Argos Soditic / Cisbio Bioassays

No EMAT : 63495
Announced Date : 14/05/2013
Type : MBO (Management Buy Out)
Deal Value : Yes
Acquirer : Private Group led by Argos Soditic

Target : Cisbio Bioassays
Country : France
Sector of activity :
  • Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 1986, Cisbio Bioassays, is a life sciences company developing and marketing products used for in-vitro diagnostics and drug discovery . > Develops various assays and reagents for...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
25/03/2014 Sinclair IS Pharma AQTIS Medical Netherlands * 63385
14/01/2014 Alliance Pharma Irenat Germany * 63373

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report